To access this element change to forms mode OFF
Grant Award View - GA201585
Investigating new targets and treatments for Alzheimer’s disease: from...
GA ID:
GA201585
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
19-Aug-2021
Publish Date:
10-Nov-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2026
Value (AUD):
$3,098,844.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Investigator Grants
Grant Activity:
Investigating new targets and treatments for Alzheimer’s disease: from biochemistry through to clinical trial
Purpose:
Alzheimer’s disease is a major disease of the elderly that causes profound impairment to cognition. This disease has proven difficult to diagnose and treat. Over the next 5 years I will take advantage of our new laboratory research to test new drugs and diagnostics for Alzheimer’s disease. I will test in a clinical trial of Alzheimer’s patients whether a drug candidate slows disease progression, and test whether new technologies can be used to diagnose Alzheimer’s disease.
GO ID:
GO Title:
Investigator Grants 2021
Internal Reference ID:
2021/GNT2008359
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA